| Product Code: ETC11589006 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India chimeric antigen receptor T-cell therapy market import shipment experienced a declining trend from 2020 to 2024, with a negative CAGR over the period. Notably, there was a significant drop in growth rate between 2023 and 2024, indicating a substantial slowdown in market expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chimeric Antigen Receptor T-cell Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Chimeric Antigen Receptor T-cell Therapy Market - Industry Life Cycle |
3.4 India Chimeric Antigen Receptor T-cell Therapy Market - Porter's Five Forces |
3.5 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Chimeric Antigen Receptor T-cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising awareness about advanced cancer treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with chimeric antigen receptor T-cell therapy |
4.3.2 Limited reimbursement options for patients |
4.3.3 Regulatory challenges and approval processes |
5 India Chimeric Antigen Receptor T-cell Therapy Market Trends |
6 India Chimeric Antigen Receptor T-cell Therapy Market, By Types |
6.1 India Chimeric Antigen Receptor T-cell Therapy Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Products, 2021 - 2031F |
6.1.4 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Platforms, 2021 - 2031F |
6.1.5 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Services, 2021 - 2031F |
6.1.6 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Clinical Trials, 2021 - 2031F |
6.2 India Chimeric Antigen Receptor T-cell Therapy Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Gene Editing Technology, 2021 - 2031F |
6.2.3 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CRISPR Gene Editing, 2021 - 2031F |
6.2.4 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Cytokine Release Syndrome, 2021 - 2031F |
6.2.5 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By T-cell Engineering, 2021 - 2031F |
6.3 India Chimeric Antigen Receptor T-cell Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.3 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.3.4 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F |
6.3.5 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4 India Chimeric Antigen Receptor T-cell Therapy Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Immunotherapy for Cancer Treatment, 2021 - 2031F |
6.4.3 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Personalized Cancer Treatment, 2021 - 2031F |
6.4.4 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Development of Targeted Cancer Therapies, 2021 - 2031F |
6.4.5 India Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Evaluation of Efficacy in Clinical Trials, 2021 - 2031F |
7 India Chimeric Antigen Receptor T-cell Therapy Market Import-Export Trade Statistics |
7.1 India Chimeric Antigen Receptor T-cell Therapy Market Export to Major Countries |
7.2 India Chimeric Antigen Receptor T-cell Therapy Market Imports from Major Countries |
8 India Chimeric Antigen Receptor T-cell Therapy Market Key Performance Indicators |
8.1 Patient survival rates post-therapy |
8.2 Number of clinical trials and research studies in the field |
8.3 Adoption rate of chimeric antigen receptor T-cell therapy in India |
9 India Chimeric Antigen Receptor T-cell Therapy Market - Opportunity Assessment |
9.1 India Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Chimeric Antigen Receptor T-cell Therapy Market - Competitive Landscape |
10.1 India Chimeric Antigen Receptor T-cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Chimeric Antigen Receptor T-cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here